Combination of betulinic acid and chidamide inhibits acute myeloid leukemia by suppression of the HIF1α pathway and generation of reactive oxygen species

Acute myeloid leukemia (AML) is a heterogeneous disorder of the hematopoietic system with no common genetic “Achilles heel” that can be targeted. Most patients respond well to standard therapy, while a majority relapse, and development of an effective therapy for AML patients is still urgently neede...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hongyu, Li, Ling, Li, Min, Huang, Xiaodong, Xie, Weiguo, Xiang, Wei, Yao, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706909/
https://www.ncbi.nlm.nih.gov/pubmed/29212263
http://dx.doi.org/10.18632/oncotarget.21889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706909/
https://www.ncbi.nlm.nih.gov/pubmed/29212263
http://dx.doi.org/10.18632/oncotarget.21889

Ejemplares similares